| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51525-0431-1 | 51525-0431 | HUMAN PRESCRIPTION DRUG | Felbamate | felbamate | TABLET | ORAL | 20111111 | 20260428 | NDA AUTHORIZED GENERIC | NDA020189 | Mylan Pharmaceuticals Inc. | FELBAMATE | 600 mg/1 | 100 TABLET in 1 BOTTLE (51525-0431-1) |
| 0037-0430-01 | 0037-0430 | HUMAN PRESCRIPTION DRUG | Felbatol | felbamate | TABLET | ORAL | 19930729 | N/A | NDA | NDA020189 | Viatris Specialty LLC | FELBAMATE | 400 mg/1 | 100 TABLET in 1 BOTTLE, PLASTIC (0037-0430-01) |
| 0037-0431-01 | 0037-0431 | HUMAN PRESCRIPTION DRUG | Felbatol | felbamate | TABLET | ORAL | 19930729 | N/A | NDA | NDA020189 | Viatris Specialty LLC | FELBAMATE | 600 mg/1 | 100 TABLET in 1 BOTTLE, PLASTIC (0037-0431-01) |